Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
100%
Antibiotics
58%
Antiinfective Agent
57%
Staphylococcus Aureus
55%
Staphylococcal Bacteremia
52%
Methicillin Resistant Staphylococcus Aureus Infection
47%
Infection
44%
Meticillin
37%
Cohort Study
34%
Vancomycin
33%
Antimicrobial Agent
31%
Staphylococcal Infection
26%
Vaccination
24%
Methicillin Susceptible Staphylococcus Aureus
24%
Spondylitis
23%
Pseudomonas aeruginosa
22%
Adverse Event
21%
Carbapenem
21%
Febrile Neutropenia
19%
Acinetobacter Baumannii
16%
Pneumonia
14%
Minimum Inhibitory Concentration
13%
Linezolid
13%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
13%
Receptor
13%
Klebsiella
13%
Nafcillin
13%
Cefazolin
13%
Measles
13%
Prospective Cohort Study
13%
Measles Antibody
13%
Malignant Neoplasm
13%
Mortality Rate
12%
Methicillin-Resistant Staphylococcus Aureus
12%
Influenza
12%
Microorganism
12%
Gram Positive Cocci
11%
Antibiotic Therapy
10%
Placebo
10%
COVID-19 Vaccine
9%
Normal Human
9%
Neutralizing Antibody
9%
Live Attenuated Influenza Vaccine
9%
Glycopeptide
8%
Recurrent Disease
8%
Case-Control Study
8%
Clinical Study
7%
Bladder Cancer
7%
Observational Study
7%
Antigen
7%
Medicine and Dentistry
Spondylitis
76%
Bloodstream Infection
69%
Antiinfective Agent
46%
Infection
39%
Antibiotics
32%
Febrile Neutropenia
26%
Patient Isolation
26%
Awareness
23%
Pseudomonas aeruginosa
23%
Antibiotic Therapy
21%
Odds Ratio
20%
Methicillin Resistant Staphylococcus Aureus Infection
19%
Blood Culture
16%
COVID-19
16%
Retrospective Cohort Study
16%
Pneumonia
16%
Retrospective Study
15%
Outpatient
15%
Gram-Negative Bacteria
15%
Methicillin Resistant Staphylococcus Aureus
15%
Tertiary Care
15%
Case-Control Study
14%
Atypical Mycobacterium
14%
Bladder Cancer
14%
Antimicrobial Agent
14%
Liver Cirrhosis
14%
Hand Hygiene
13%
Antibiogram
13%
Invasive Aspergillosis
13%
Intervertebral Disk Degeneration
13%
Tuberculous Spondylitis
13%
Middle East Respiratory Syndrome Coronavirus
13%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
13%
Mycobacterium bovis
13%
Aortic Aneurysm
13%
Klebsiella
13%
Needle Biopsy
13%
Lung Tuberculosis
13%
Middle East Respiratory Syndrome
13%
Enterobacteriaceae
13%
Catheter Infection
13%
Cholera
13%
Typhoid Fever
13%
Escherichia Coli Infection
13%
Adverse Event
13%
Antimicrobial Therapy
13%
Immunization Registry
13%
Gene Linkage
13%
Surveillance System
13%
Bacillary Dysentery
13%
Immunology and Microbiology
Staphylococcus Aureus
95%
Infection
75%
Methicillin-Resistant Staphylococcus Aureus
57%
Antimicrobial Agent
33%
Minimum Inhibitory Concentration
29%
Abscess
27%
C-Reactive Protein
26%
Microorganism
26%
Mortality Rate
25%
Gram-Negative Bacteria
25%
Acinetobacter Baumannii
23%
COVID-19
22%
Methicillin Susceptible Staphylococcus Aureus
22%
Neutrophil
19%
Antibiotic Sensitivity
19%
Comorbidity
16%
Soft Tissue
15%
Inoculum
15%
Leukocyte Count
15%
Tissue Culture
15%
Thoracic Spine
15%
Escherichia coli
14%
Nontuberculous mycobacteria
14%
Endocarditis
14%
Seropositivity
14%
TLR2
13%
down Regulation
13%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
13%
Serotype
13%
Mycobacterium bovis
13%
Klebsiella
13%
Receptor Binding
13%
Cytokine
13%
Middle East Respiratory Syndrome
13%
Middle East Respiratory Syndrome Coronavirus
13%
Streptococcus Pneumonia
13%
Enterobacterales
13%
Pseudomonas aeruginosa
11%
Methicillin Resistance
11%
Immunogenicity
10%
Neutralizing Antibody
10%
Infectious Agent
9%
Erythrocyte Sedimentation Rate
8%
Hospital Mortality
8%
Antigen
7%
Vertebral Column
7%
Chromosome
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Multiplex Polymerase Chain Reaction
7%
Real Time Polymerase Chain Reaction
7%